These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16843267)
21. TYK2 is a key regulator of the surveillance of B lymphoid tumors. Stoiber D; Kovacic B; Schuster C; Schellack C; Karaghiosoff M; Kreibich R; Weisz E; Artwohl M; Kleine OC; Muller M; Baumgartner-Parzer S; Ghysdael J; Freissmuth M; Sexl V J Clin Invest; 2004 Dec; 114(11):1650-8. PubMed ID: 15578097 [TBL] [Abstract][Full Text] [Related]
22. STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. Moles R; Bellon M; Nicot C Neoplasia; 2015 May; 17(5):449-62. PubMed ID: 26025667 [TBL] [Abstract][Full Text] [Related]
24. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Heuser M; Sly LM; Argiropoulos B; Kuchenbauer F; Lai C; Weng A; Leung M; Lin G; Brookes C; Fung S; Valk PJ; Delwel R; Löwenberg B; Krystal G; Humphries RK Blood; 2009 Nov; 114(19):3983-93. PubMed ID: 19667399 [TBL] [Abstract][Full Text] [Related]
25. p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo. Zou X; Cong F; Coutts M; Cattoretti G; Goff SP; Calame K Mol Cell Biol; 2000 Jan; 20(2):628-33. PubMed ID: 10611241 [TBL] [Abstract][Full Text] [Related]
26. STAT1 signaling shields T cells from NK cell-mediated cytotoxicity. Kang YH; Biswas A; Field M; Snapper SB Nat Commun; 2019 Feb; 10(1):912. PubMed ID: 30796216 [TBL] [Abstract][Full Text] [Related]
27. In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels. Belloni E; Shing D; Tapinassi C; Viale A; Mancuso P; Malazzi O; Gerbino E; Dall'Olio V; Egurbide I; Odero MD; Bertolini F; Pelicci PG Leukemia; 2011 Apr; 25(4):733-6. PubMed ID: 21252985 [No Abstract] [Full Text] [Related]
28. Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Schneckenleithner C; Bago-Horvath Z; Dolznig H; Neugebauer N; Kollmann K; Kolbe T; Decker T; Kerjaschki D; Wagner KU; Müller M; Stoiber D; Sexl V Oncotarget; 2011 Dec; 2(12):1043-54. PubMed ID: 22185785 [TBL] [Abstract][Full Text] [Related]
29. Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice. Boyer B; Gisselbrecht S; Debre P; McKenzie I; Levy JP J Immunol; 1980 Oct; 125(4):1415-20. PubMed ID: 7410844 [No Abstract] [Full Text] [Related]
30. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. Shresta S; Sharar KL; Prigozhin DM; Snider HM; Beatty PR; Harris E J Immunol; 2005 Sep; 175(6):3946-54. PubMed ID: 16148142 [TBL] [Abstract][Full Text] [Related]
31. Biological characterization of pegylated interferons: a case study. Xie L; Cullen C; Bradshaw S; DeLorenzo M; Grace MJ Methods Mol Biol; 2005; 308():319-35. PubMed ID: 16082045 [No Abstract] [Full Text] [Related]
32. STAT1 drives tumor progression in serous papillary endometrial cancer. Kharma B; Baba T; Matsumura N; Kang HS; Hamanishi J; Murakami R; McConechy MM; Leung S; Yamaguchi K; Hosoe Y; Yoshioka Y; Murphy SK; Mandai M; Hunstman DG; Konishi I Cancer Res; 2014 Nov; 74(22):6519-30. PubMed ID: 25267067 [TBL] [Abstract][Full Text] [Related]
33. Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis. Park J; Kim J; Park B; Yang KM; Sun EJ; Tognon CE; Sorensen PH; Kim SJ Oncogene; 2018 Apr; 37(17):2270-2284. PubMed ID: 29391602 [TBL] [Abstract][Full Text] [Related]
34. Replenishment of the B cell compartment after doxorubicin-induced hematopoietic toxicity is facilitated by STAT1. Datta S; Parajuli N; Tymoszuk P; Ottina E; Parson W; Sgonc R; Villunger A; Doppler W J Leukoc Biol; 2014 Jun; 95(6):853-66. PubMed ID: 24295829 [TBL] [Abstract][Full Text] [Related]
35. Role of MHC class I in immune surveillance of mitochondrial DNA integrity. Gu Y; Wang C; Roifman CM; Cohen A J Immunol; 2003 Apr; 170(7):3603-7. PubMed ID: 12646623 [TBL] [Abstract][Full Text] [Related]
36. [Features of the process of chromatin denaturation in leukemic tissue and murine spleen cells]. Monacelidze DR; Madzhagaladze GV; Bakradze NG; Birkaia VG; Sapozhnikova NA; Asatiani NV Biofizika; 1999; 44(5):910-3. PubMed ID: 10624533 [TBL] [Abstract][Full Text] [Related]
37. A DNA vaccine against acute promyelocytic leukemia in the mouse. Rosti V Haematologica; 2005 Aug; 90(8):1010B. PubMed ID: 16079090 [No Abstract] [Full Text] [Related]
38. [Simple model for evaluation of radiation injury of tumor cells in the body of animals]. Konopliannikov AG Med Radiol (Mosk); 1975 Jan; 20(1):47-9. PubMed ID: 1128191 [No Abstract] [Full Text] [Related]
40. [Immunogenetic control over the spontaneous regression of Rauscher leukemia in mice]. Klepikov NN Dokl Akad Nauk SSSR; 1980; 255(1):250-2. PubMed ID: 7460751 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]